Next Article in Journal
Combined Supplementation of Pre-Exercise Carbohydrate, Alanine, and Proline and Continuous Intake of Green Tea Catechins Effectively Boost Endurance Performance in Mice
Previous Article in Journal
Testing the Feasibility and Preliminary Efficacy of an 8-Week Exercise and Compensatory Eating Intervention
Open AccessArticle

“Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial

1
Department of Internal Medicine (I), Osaka Medical College, 2-7 Daigaku-machi, Takatsuki 569-8686, Japan
2
National Agriculture and Food Research Organization, Agri-Food Business Innovation Center, 3-1-1 Kannondai, Tsukuba 305-8517, Japan
3
Division of Applied Biological Chemistry, Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka 812-8581, Japan
4
Sakai City Medical Center, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai 593-8304, Japan
*
Author to whom correspondence should be addressed.
Nutrients 2018, 10(7), 924; https://doi.org/10.3390/nu10070924
Received: 18 June 2018 / Revised: 14 July 2018 / Accepted: 17 July 2018 / Published: 19 July 2018
(1) Background: Arteriosclerosis is associated with high levels of low-density lipoprotein (LDL) cholesterol. O-methylated catechins in “Benifuuki” green tea are expected to reduce cholesterol levels, although there is limited research regarding this topic; (2) Methods: This trial evaluated 159 healthy volunteers who were randomized to receive ice cream containing a high-dose of “Benifuuki” extract including 676 mg of catechins (group H), a low-dose of “Benifuuki” extract including 322 mg of catechins (group L), or no “Benifuuki” extract (group C). Each group consumed ice cream (with or without extract) daily for 12 weeks, and their lipid-related parameters were compared; (3) Results: A significant reduction in the level of lectin-like oxidized LDL receptor-1 ligand containing ApoB (LAB) was detected in group H, compared to groups L and C. No significant differences between the three groups were detected in their levels of total cholesterol, triglycerides, and LDL cholesterol; (4) Conclusions: “Benifuuki” extract containing O-methylated catechins may help prevent arteriosclerosis. View Full-Text
Keywords: dyslipidemia; Benifuuki; O-methylated catechin; Lectin-like oxidized LDL receptor-1; LOX-1 ligand dyslipidemia; Benifuuki; O-methylated catechin; Lectin-like oxidized LDL receptor-1; LOX-1 ligand
Show Figures

Graphical abstract

MDPI and ACS Style

Miyawaki, M.; Sano, H.; Imbe, H.; Fujisawa, R.; Tanimoto, K.; Terasaki, J.; Maeda-Yamamoto, M.; Tachibana, H.; Hanafusa, T.; Imagawa, A. “Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial. Nutrients 2018, 10, 924.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop